Virtu Financial’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,029
| Closed | -$65K | – | 1791 |
|
|
2023
Q2 | $65K | Buy |
+5,029
| New | +$65K | 0.01% | 1101 |
|
|
2022
Q3 | – | Sell |
-24,523
| Closed | -$277K | – | 2153 |
|
|
2022
Q2 | $277K | Buy |
+24,523
| New | +$277K | 0.02% | 615 |
|
|
2021
Q2 | – | Sell |
-3,846
| Closed | -$132K | – | 1986 |
|
|
2021
Q1 | $132K | Buy |
+3,846
| New | +$132K | 0.01% | 1228 |
|
|
2020
Q4 | – | Sell |
-4,564
| Closed | -$110K | – | 1736 |
|
|
2020
Q3 | $110K | Buy |
4,564
+910
| +25% | +$21.9K | 0.02% | 704 |
|
|
2020
Q2 | $67K | Buy |
+3,654
| New | +$67K | 0.01% | 960 |
|
|
2019
Q3 | – | Sell |
-2,580
| Closed | -$67K | – | 1760 |
|
|
2019
Q2 | $67K | Buy |
2,580
+771
| +43% | +$20K | ﹤0.01% | 1184 |
|
|
2019
Q1 | $46K | Sell |
1,809
-4,709
| -72% | -$120K | ﹤0.01% | 1213 |
|
|
2018
Q4 | $150K | Sell |
6,518
-3,643
| -36% | -$83.8K | 0.01% | 1027 |
|
|
2018
Q3 | $326K | Buy |
+10,161
| New | +$326K | 0.02% | 806 |
|